FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2400405171> ?p ?o ?g. }

• W2400405171 endingPage "38844" @default.
• W2400405171 startingPage "38835" @default.
• W2400405171 abstract "The contribution of integrin α6β4 (α6β4) overexpression to the pancreatic cancer invasion and metastasis has been previously shown. We have reported immunotargeting of α6β4 for radionuclide-based and near-infrared fluorescence imaging in a pancreatic cancer model. In this study, we prepared yttrium-90 labeled anti-α6β4 antibody (90Y-ITGA6B4) and evaluated its radioimmunotherapeutic efficacy against pancreatic cancer xenografts in nude mice. Mice bearing xenograft tumors were randomly divided into 5 groups: (1) single administration of 90Y-ITGA6B4 (3.7MBq), (2) double administrations of 90Y-ITGA6B4 with once-weekly schedule (3.7MBq x 2), (3) single administration of unlabeled ITGA6B4, (4) double administrations of unlabeled ITGA6B4 with once-weekly schedule and (5) the untreated control. Biweekly tumor volume measurements and immunohistochemical analyses of tumors at 2 days post-administration were performed to monitor the response to treatments. To assess the toxicity, body weight was measured biweekly. Additionally, at 27 days post-administration, blood samples were collected through cardiac puncture, and hematological parameters, hepatic and renal functions were analyzed. Both 90Y-ITGA6B4 treatment groups showed reduction in tumor volumes (P < 0.04), decreased cell proliferation marker Ki-67-positive cells and increased DNA damage marker p-H2AX-positive cells, compared with the other groups. Mice treated with double administrations of 90Y-ITGA6B4, exhibited myelosuppression. There were no significant differences in hepatic and renal functions between the 2 treatment groups and the other groups. Our results suggest that 90Y-ITGA6B4 is a promising radioimmunotherapeutic agent against α6β4 overexpressing tumors. In the future studies, dose adjustment for fractionated RIT should be considered carefully in order to get the optimal effect while avoiding myelotoxicity." @default.
• W2400405171 created "2016-06-24" @default.
• W2400405171 creator A5017677055 @default.
• W2400405171 creator A5030574164 @default.
• W2400405171 creator A5035001561 @default.
• W2400405171 creator A5038612225 @default.
• W2400405171 creator A5054029619 @default.
• W2400405171 creator A5058140945 @default.
• W2400405171 creator A5078877030 @default.
• W2400405171 creator A5082279355 @default.
• W2400405171 creator A5090371551 @default.
• W2400405171 date "2016-05-26" @default.
• W2400405171 modified "2023-09-27" @default.
• W2400405171 title "Radioimmunotherapy of pancreatic cancer xenografts in nude mice using 90Y-labeled anti-α6β4 integrin antibody" @default.
• W2400405171 cites W1524559436 @default.
• W2400405171 cites W1568059965 @default.
• W2400405171 cites W1670574656 @default.
• W2400405171 cites W1757407923 @default.
• W2400405171 cites W1759376742 @default.
• W2400405171 cites W1829445575 @default.
• W2400405171 cites W1955565662 @default.
• W2400405171 cites W1974208182 @default.
• W2400405171 cites W1974370610 @default.
• W2400405171 cites W1985775217 @default.
• W2400405171 cites W1989074212 @default.
• W2400405171 cites W1990753829 @default.
• W2400405171 cites W2006461861 @default.
• W2400405171 cites W2013466786 @default.
• W2400405171 cites W2028976948 @default.
• W2400405171 cites W2029231027 @default.
• W2400405171 cites W2036145275 @default.
• W2400405171 cites W2040483132 @default.
• W2400405171 cites W2043303586 @default.
• W2400405171 cites W2043334853 @default.
• W2400405171 cites W2077556181 @default.
• W2400405171 cites W2079142824 @default.
• W2400405171 cites W2079666724 @default.
• W2400405171 cites W2080010071 @default.
• W2400405171 cites W2094108414 @default.
• W2400405171 cites W2094476236 @default.
• W2400405171 cites W2110117054 @default.
• W2400405171 cites W2112269002 @default.
• W2400405171 cites W2137463464 @default.
• W2400405171 cites W2138501321 @default.
• W2400405171 cites W2139975144 @default.
• W2400405171 cites W2146583638 @default.
• W2400405171 cites W2147000598 @default.
• W2400405171 cites W2152393478 @default.
• W2400405171 cites W2168486198 @default.
• W2400405171 cites W2179149979 @default.
• W2400405171 cites W2214865607 @default.
• W2400405171 cites W2416705229 @default.
• W2400405171 cites W29036513 @default.
• W2400405171 doi "https://doi.org/10.18632/oncotarget.9631" @default.
• W2400405171 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5122433" @default.
• W2400405171 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27246980" @default.
• W2400405171 hasPublicationYear "2016" @default.
• W2400405171 type Work @default.
• W2400405171 sameAs 2400405171 @default.
• W2400405171 citedByCount "14" @default.
• W2400405171 countsByYear W24004051712017 @default.
• W2400405171 countsByYear W24004051712018 @default.
• W2400405171 countsByYear W24004051712019 @default.
• W2400405171 countsByYear W24004051712020 @default.
• W2400405171 countsByYear W24004051712021 @default.
• W2400405171 countsByYear W24004051712022 @default.
• W2400405171 crossrefType "journal-article" @default.
• W2400405171 hasAuthorship W2400405171A5017677055 @default.
• W2400405171 hasAuthorship W2400405171A5030574164 @default.
• W2400405171 hasAuthorship W2400405171A5035001561 @default.
• W2400405171 hasAuthorship W2400405171A5038612225 @default.
• W2400405171 hasAuthorship W2400405171A5054029619 @default.
• W2400405171 hasAuthorship W2400405171A5058140945 @default.
• W2400405171 hasAuthorship W2400405171A5078877030 @default.
• W2400405171 hasAuthorship W2400405171A5082279355 @default.
• W2400405171 hasAuthorship W2400405171A5090371551 @default.
• W2400405171 hasBestOaLocation W24004051711 @default.
• W2400405171 hasConcept C121608353 @default.
• W2400405171 hasConcept C126322002 @default.
• W2400405171 hasConcept C142724271 @default.
• W2400405171 hasConcept C150903083 @default.
• W2400405171 hasConcept C159654299 @default.
• W2400405171 hasConcept C203014093 @default.
• W2400405171 hasConcept C204232928 @default.
• W2400405171 hasConcept C207001950 @default.
• W2400405171 hasConcept C25938499 @default.
• W2400405171 hasConcept C2776146153 @default.
• W2400405171 hasConcept C2778764654 @default.
• W2400405171 hasConcept C2779013556 @default.
• W2400405171 hasConcept C2780210213 @default.
• W2400405171 hasConcept C29730261 @default.
• W2400405171 hasConcept C502942594 @default.
• W2400405171 hasConcept C542903549 @default.
• W2400405171 hasConcept C71924100 @default.
• W2400405171 hasConcept C86803240 @default.
• W2400405171 hasConcept C90924648 @default.
• W2400405171 hasConceptScore W2400405171C121608353 @default.
• W2400405171 hasConceptScore W2400405171C126322002 @default.

• next